English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Trytosaveabit commented on a stock · Nov 12, 2024 21:13

Update

$Moleculin Biotech (MBRX.US)$ Moleculin Receives Institutional Review Board Approval for Miracle Phase 3 Pivotal Trial of Annamycin in Combination With Cytarabine for the Treatment of R/R Acute Myeloid Leukemia (Aml)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2068 Views
Comment
Sign in to post a comment
    avatar
    Trytosaveabit
    4487
    Followers
    25
    Following
    63K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartLatest Price
    NVDA
    NVIDIA
    -- 131.760
    TSLA
    Tesla
    -- 396.360
    RGTI
    Rigetti Computing
    -- 8.9500
    AMD
    Advanced Micro Devices
    -- 116.090
    PLTR
    Palantir
    -- 65.910
    Trump's comeback to the Office
    Following Trump's Policies to Seek Investment Opportunities
    Discussing
    Trump 2.0 countdown: What's the next big opportunity in the markets?
    🎙️️ Discussion: 1. Could Trump's cryptocurrency policies potentially benefit the crypto market? 2. Might his tariff policies have a positiv Show More
    Trump 2.0 Opportunity Preview: Guess the market winner before the president takes office!